Literature DB >> 2824046

Phase II study of isotretinoin in the treatment of advanced non-small cell lung cancer.

S M Grunberg1, L M Itri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2824046

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  A phase II trial of a differentiating agent (tRA) with cisplatin-VP 16 chemotherapy in advanced non-small cell lung cancer.

Authors:  R Thiruvengadam; J O Atiba; S H Azawi
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

2.  Progressive paresthesias after cessation of therapy with very high-dose cisplatin.

Authors:  S M Grunberg; S Sonka; L L Stevenson; F M Muggia
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Pulmonary availability of isotretinoin in rats after inhalation of a powder aerosol.

Authors:  S M Raleigh; R D Verschoyle; C Bowskill; U Pastorino; J N Staniforth; F Steele; D Dinsdale; P Carthew; C K Lim; J Silvester; A Gescher
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.